NECLIFE
Start SIP
Invest Now
Start SIP in NECLIFE
Nectar Lifesciences live price: ₹11.71. It opened at ₹12 vs previous close ₹12; intraday high/low: ₹12/₹12. The 50 & 200 DMA stand at ₹14.25/₹17.96.
Nectar Lifesciences Performance
- Low
- ₹12
- High
- ₹12
- 52 Week Low
- ₹11
- 52 Week High
- ₹30
- Open Price₹12
- Previous Close₹12
- Volume192,255
- 50 DMA₹14.25
- 100 DMA₹15.50
- 200 DMA₹17.96
Investment Returns
- Over 1 Month -12.94%
- Over 3 Month -42.74%
- Over 6 Month -17.3%
- Over 1 Year -59.94%
Smart Investing Starts Here Start SIP with Nectar Lifesciences for Steady Growth!
Nectar Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.7
- PEG Ratio
- 0
- Market Cap Cr
- 263
- P/B Ratio
- 0.4
- Average True Range
- 0.49
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -0.86
- RSI
- 25.35
- MFI
- 10.19
Nectar Lifesciences Financials
Nectar Lifesciences Technicals
EMA & SMA
Current Price
₹11.71
-0.08
(-0.68%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹12.73
- 50 Day
- ₹14.25
- 100 Day
- ₹15.50
- 200 Day
- ₹17.96
Resistance and Support
11.78
- R3 12.13
- R2 12.04
- R1 11.87
- S1 11.61
- S2 11.52
- S3 11.35
Nectar Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & Others | To consider other business matters. |
| 2025-07-23 | Others | Inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st EGM or matters related thereto. |
| 2025-07-07 | Audited Results |
Nectar Lifesciences F&O
About Nectar Lifesciences
- NSE Symbol
- NECLIFE
- BSE Symbol
- 532649
- Chairman & Managing Director
- Mr. Sanjiv Goyal
- ISIN
- INE023H01027
Similar Stocks to Nectar Lifesciences
Nectar Lifesciences FAQs
Nectar Lifesciences share price is ₹11 As on 09 March, 2026 | 08:28
The Market Cap of Nectar Lifesciences is ₹262.6 Cr As on 09 March, 2026 | 08:28
The P/E ratio of Nectar Lifesciences is -0.7 As on 09 March, 2026 | 08:28
The PB ratio of Nectar Lifesciences is 0.4 As on 09 March, 2026 | 08:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.